Search clinical trials for: IPX066 95 mg LD
Total 17 results
-
Impax Laboratories, LLCCompletedA Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease (APEX-PD)Parkinson's DiseaseUnited States, Canada, Estonia, Latvia, Lithuania, Romania, Ukraine
-
Impax Laboratories, LLCCompletedParkinson's DiseaseUnited States, Canada, Estonia, Latvia, Lithuania, Romania, Ukraine, Germany, Poland, Spain
-
Impax Laboratories, LLCCompletedIdiopathic Parkinson's DiseaseUnited States
-
Impax Laboratories, LLCCompletedParkinson's DiseaseUnited States
-
Impax Laboratories, LLCCompletedIdiopathic Parkinson's DiseaseUnited States
-
Impax Laboratories, LLCCompletedMultiple SclerosisUnited States, Canada, Estonia, Latvia, Ukraine
-
Impax Laboratories, LLCCompletedParkinson's DiseaseUnited States
-
Impax Laboratories, LLCCompletedParkinson's DiseaseUnited States
-
Impax Laboratories, LLCCompletedParkinson's DiseaseUnited States, Canada, France, Germany, Poland, Romania, Spain, Ukraine
-
Impax Laboratories, LLCMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson's DiseaseUnited States
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
IRCCS San Raffaele RomaSynAgile CorporationCompleted
-
Taiwan Liposome CompanyCompletedOsteoarthritis of the KneeTaiwan, Australia
-
RedHill Biopharma LimitedCompletedCrohn DiseaseUnited States, Canada, Czechia, Israel, New Zealand, Poland, Serbia
-
Korea University Anam HospitalCompleted
-
AbbVieCompletedUterine Fibroids | Heavy Uterine Bleeding
-
Al-Azhar UniversityCompleted